CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata

NCT03137381 ·Status: COMPLETED ·Phase: PHASE2

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

NCT03570749 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Computer-Assisted Hair Restoration Study Using ARTAS System

NCT05938569 ·Status: RECRUITING ·Phase: NA

Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated Factors

NCT05588310 ·Status: UNKNOWN

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata

NCT06826196 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata

NCT02974868 ·Status: COMPLETED ·Phase: PHASE2

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

NCT03495817 ·Status: COMPLETED ·Phase: PHASE2

European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

NCT05041803 ·Status: COMPLETED ·Phase: PHASE3

Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata

NCT05368103 ·Status: COMPLETED ·Phase: PHASE2

Long-Term PF-06651600 for the Treatment of Alopecia Areata

NCT04006457 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

NCT04784533 ·Status: COMPLETED ·Phase: PHASE2

Alopecia Areata Registry

NCT00069589 ·Status: ACTIVE_NOT_RECRUITING

Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata

NCT05470413 ·Status: UNKNOWN ·Phase: PHASE3

Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata

NCT05599607 ·Status: COMPLETED ·Phase: NA

Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

NCT06531109 ·Status: RECRUITING

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

NCT07029828 ·Status: RECRUITING ·Phase: PHASE3

Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin

NCT00408798 ·Status: COMPLETED ·Phase: NA

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

NCT03315689 ·Status: COMPLETED ·Phase: PHASE2

A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

NCT03899259 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

NCT06747611 ·Status: RECRUITING ·Phase: PHASE2

A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

NCT07029711 ·Status: RECRUITING ·Phase: PHASE3

A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata

NCT01917058 ·Status: WITHDRAWN ·Phase: PHASE2

Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata

NCT03800979 ·Status: COMPLETED ·Phase: PHASE4

Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata

NCT01950780 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.

NCT07205159 ·Status: RECRUITING ·Phase: PHASE1